Stockreport

Bioventus Non-GAAP EPS of $0.24 beats by $0.02, revenue of $157.9M beats by $2.95M [Seeking Alpha]

Bioventus Inc. - Class A  (BVS) 
PDF Bioventus introduced its financial guidance for full-year 2026. The Company expects: Net sales of $600 million to $610 million vs $604.18M consensus. This reflects [Read more]